Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs in the Chronic Kidney Disease Population: Are They Rational or Reckless?

J Karri, RS D'Souza, EJ Wang - Anesthesia & Analgesia, 2024 - journals.lww.com
Since its approval in 1984 by the United States Food and Drug Administration for over-
thecounter (OTC) use as the first nonaspirin nonsteroidal anti-inflammatory drug (NSAID) …

Physical activity intensity and markers of inflammation in those with non-alcoholic fatty liver disease

JE Harden, L Tabacu, LJ Reynolds - Diabetes Research and Clinical …, 2024 - Elsevier
Aims To investigate associations between objectively measured light (LPA) and moderate-to-
vigorous (MVPA) physical activity on plasma homocysteine and serum C-reactive protein …

Prevalence and assessment of risk factors of chronic kidney disease in the ASIR region of Saudi Arabia

M Alshahrani, LZ Almalki, NA Hasoosah… - Annals of Medicine …, 2024 - journals.lww.com
Results: A total of 967 participants were included in the study, with a CKD prevalence rate of
1.9%. Gender, history of acute kidney disease, obstructive sleep apnea, family history of …

Особенности Поражения Почек У Больных Ревматоидным Артритом В Бухарской Области

ТБ Тилавов, КУ Газиев - Miasto Przyszłości, 2024 - miastoprzyszlosci.com.pl
Целью данной работы является проведение общего анализа соответствующей
литературы по проблеме повреждения почек у пациентов с ревматоидным артритом …